FASN and tuberculosis: This has been in part due to studies of isoniazid, a first-line tuberculosis treatment that has been used for over 70 years through bacterial growth inhibition via the suppression of enoyl-acyl carrier protein reductase, mycolic acids, and mycobacterial cell wall synthesis (75).